The World Health Organisation's regional director for Africa makes plans to tackle Ebola, plus more from AstraZeneca, TransCelerate, AmerisourceBergen, and more.
Catering for low value, high volume customers as well as the growing number of firms developing complex drugs will be a big challenge in the era of personalised medicine according to experts speaking at a London conference this week.
In an Outsourcing-Pharma sporting special, we reveal why GSK will not be at the Rio Olympics, why PPD has renewed its ironman triathlon sponsorship, and what became of BMS' partnership with Lance Armstrong .
